Peer-reviewed veterinary case report
New valve device shows early success for mitral regurgitation in dogs
By Liu, Bo et al.·Published in Frontiers in veterinary science·2020·College of Veterinary Medicine, China·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs.
- Species:
- dog
Plain-English summary
Eight dogs with mitral valve regurgitation, a heart condition that can lead to serious problems, were treated with a new device called ValveClamp. This device was used to help close the valve properly, and all dogs successfully underwent the procedure without any complications. After the treatment, echocardiograms showed a significant improvement in the severity of their heart condition. The dogs were monitored closely, and they all survived the procedure well.
People also search for: dog mitral valve regurgitation treatment · ValveClamp for dogs · heart problems in dogs · dog heart surgery recovery · how to manage dog heart disease
Abstract
Veterinary management of mitral valve regurgitation due to mxyomatous valve disease in dogs is limited to medical treatments, which only postpones the onset of congestive heart failure or alleviates clinical symptoms. Most surgical procedures to manage this condition in humans require cardiopulmonary bypass and have a high risk of complications.Eight dogs with naturally occurring mitral valve regurgitation.Prospective observational study. All dogs were treated with a novel edge-to-edge transcatheter device named ValveClamp. The total surgical procedural time and total catheterization time were recorded. Echocardiographic variables measured pre- and post-procedure were compared using Wilcoxin-signed rank test with a< 0.05 considered significant. Data were expressed as median and interquartile range and absolute numbers and percentages.The procedural success rate was 100% and all the dogs survived without complications. The median (interquartile range) total surgical procedural time was 86.5 (76-96.2) minutes and catheterization time was 23.5 (22-33.8) minutes. Echocardiography revealed a significant reduction in mitral regurgitation severity in all dogs following the procedure based on both a reduced mitral regurgitant maximum jet area (= 0.012) and a reduced mitral regurgitant maximum jet area to left atrial area (= 0.018).The ValveClamp device is effective at reducing the severity of mitral regurgitation in dogs with naturally occurring myxomatous valve disease.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33392290/